Dan K - Search Results

1

Activation of bcr-abl fusion gene and ras oncogenes in chronic myelogenous leukemia.

Futaki M, Inokuchi K, Dan K, Nomura T. Futaki M, et al. Among authors: dan k. Leuk Lymphoma. 1991;5(2-3):163-9. doi: 10.3109/10428199109068121. Leuk Lymphoma. 1991. PMID: 21269077

2

N-RAS activation in the terminal stage of undifferentiated chronic myeloproliferative disease.

Inokuchi K, Futaki M, Miyake K, Kuwabara T, Shinohara T, Dan K, Nomura T. Inokuchi K, et al. Among authors: dan k. Int J Hematol. 1992 Aug;56(1):9-15. Int J Hematol. 1992. PMID: 1391809

3

Relationship of the type of bcr-abl hybrid mRNA to clinical course and transforming activity in Philadelphia-positive chronic myelogenous leukemia.

Futaki M, Inokuchi K, Matsuoka H, Miyake K, Dan K, Nomura T. Futaki M, et al. Among authors: dan k. Leuk Res. 1992 Nov;16(11):1071-5. doi: 10.1016/0145-2126(92)90045-9. Leuk Res. 1992. PMID: 1434743

4

A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia.

Inokuchi K, Inoue T, Tojo A, Futaki M, Miyake K, Yamada T, Tanabe Y, Ohki I, Dan K, Ozawa K, et al. Inokuchi K, et al. Among authors: dan k. Blood. 1991 Dec 15;78(12):3125-7. Blood. 1991. PMID: 1742479 Free article.

5

The relationship between the site of breakpoints within the bcr gene and thrombopoiesis of Philadelphia-positive chronic myelocytic leukemia.

Inokuchi K, Futaki M, Yamada T, Tanabe Y, Dan K, Shinohara T, Kuriya S, Nomura T. Inokuchi K, et al. Among authors: dan k. Leuk Res. 1991;15(11):1067-73. doi: 10.1016/0145-2126(91)90113-8. Leuk Res. 1991. PMID: 1961010

6

Possible correlation of b3-a2-type bcr-abl messenger RNA defined by semiquantitative RT-PCR to platelet and megakaryocyte counts in Philadelphia-positive chronic myelogenous leukemia.

Inokuchi K, Futaki M, Dan K, Nomura T. Inokuchi K, et al. Among authors: dan k. Intern Med. 1994 Apr;33(4):189-92. doi: 10.2169/internalmedicine.33.189. Intern Med. 1994. PMID: 7520786 Free article.

7

Dual rearrangement of immunoglobulin and T-cell receptor genes in a case of splenic lymphoma with villous lymphocytes.

Hanawa H, Abo J, Inokuchi K, Tanosaki S, Matuoka H, Miyake K, Futaki M, Dan K, Nomura T. Hanawa H, et al. Among authors: dan k. Leuk Lymphoma. 1995 Jul;18(3-4):357-60. doi: 10.3109/10428199509059631. Leuk Lymphoma. 1995. PMID: 8535206

8

Possible transforming activity of interferon regulatory factor 2 in tumorigenicity assay of NIH3T3 cells transfected with DNA from chronic myelogenous leukemia patients.

Futaki M, Inokuchi K, Hanawa H, Tanosaki S, Dan K, Nomura T. Futaki M, et al. Among authors: dan k. Leuk Res. 1996 Jul;20(7):601-5. doi: 10.1016/0145-2126(96)00013-6. Leuk Res. 1996. PMID: 8795694

9

Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.

Inokuchi K, Iwakiri R, Futaki M, Hanawa H, Tanosaki S, Nomura T, Dan K. Inokuchi K, et al. Among authors: dan k. Leuk Lymphoma. 1998 May;29(5-6):553-61. doi: 10.3109/10428199809050915. Leuk Lymphoma. 1998. PMID: 9643569

10

Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.

Yamaguchi H, Inokuchi K, Sakuma Y, Dan K. Yamaguchi H, et al. Among authors: dan k. Leukemia. 2001 Nov;15(11):1729-34. doi: 10.1038/sj.leu.2402265. Leukemia. 2001. PMID: 11681414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters